News

How Japan ‘Changed the System’

8 years ago Nov 15, 2015

Japan’s Bold Steps By: Iain Marlow ASUKE, JAPAN The Globe and Mail Last updated: Saturday, Nov....

RepliCel Executives to Present at 9th World Congress for Hair Research in Miami

8 years ago Nov 11, 2015

Conference brings together hair biologists, dermatologists, cosmetic scientists and leading biotech companies to discuss the...

RepliCel Selected as One of This Year’s Top 20 Public Canadian Technology Companies

8 years ago Nov 03, 2015

Canadian Innovation Exchange (CIX) Public Investor Day November 18 at Toronto’s MaRS Discovery District to...

Canada’s emerging cell therapy biotech industry

8 years ago Oct 26, 2015

Canadian companies driving global breakthroughs in regenerative medicine By Kathryn Boothby To read this article...

First Participants Enrolled in RepliCel’s Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable

8 years ago Oct 19, 2015

Testing the use of a cell-based injectable as a regenerative alternative for the global dermal...

RepliCel Life Sciences Inc. Announces Brokered Private Placement

8 years ago Oct 19, 2015

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FORDISSEMINATION IN THE UNITED STATES...

Industry Leader Geoff MacKay Joins RepliCel Life Sciences’ Board of Directors

8 years ago Oct 14, 2015

VANCOUVER, BC – October 15, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP),...

RepliCel Announces October Presentation and Partnering Meeting Schedule

8 years ago Oct 07, 2015

VANCOUVER, BC – October 8, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP),...

RepliCel Presenting at Two Upcoming Investment and Partnering Forums

9 years ago Sep 22, 2015

A Chinese-based investor forum in Toronto and an aesthetics & dermatology conference in Newport Beach...

Japan’s regulatory gamble and what it means for the Industry

9 years ago Sep 15, 2015

Navigating the Global Regulatory Landscape Written by: Lee Buckler & Colin Lee Novick The Follower...

RepliCel Life Sciences Announces Initiation of Clinical Site and Participant Recruitment for European Skin Aging Study

9 years ago Sep 14, 2015

Clinical trial site located at IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in GermanyVANCOUVER, BC –...

Alan Leong of BioWatch Looks Beyond the Buzz for Solid Early-Stage Plays RP, CAPR, CTRV, CPXX, SRNE, SNSS

9 years ago Sep 08, 2015

To read the full article as it appears on The Life Sciences Report, click here....

RepliCel Life Sciences Cleared to Initiate Clinical Trial of RCS-01 for Dermal Rejuvenation

9 years ago Sep 04, 2015

Patient recruitment will take place at the IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in Germany...

RepliCel Reports Second Quarter 2015 Financial Results

9 years ago Aug 27, 2015

VANCOUVER, BC – August 28, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP),...

Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital’s Eden Rahim

9 years ago Aug 11, 2015

To read the full article as it appears on The Life Science Report, please click...

Regenerative Medicine in Japan: CJ Partners’ Colin Lee Novick

9 years ago Aug 04, 2015

Source: Gail Dutton of The Life Sciences Report Regenerative medicine is just beginning to be...

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis

9 years ago Aug 02, 2015

Conference attracts investment professionals in the Twin Cities area VANCOUVER, BC – August 3, 2015...

RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype

9 years ago Jul 28, 2015

Novel features of next-generation design promise to serve and expand the dermal injectable marketVANCOUVER, BC...

RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial

9 years ago Jul 20, 2015

German-based trial to test RCS-01 cell therapy treatment for aged and sun-damaged skin VANCOUVER, BC...

5 Questions with David Hall

9 years ago Jul 15, 2015

Click here to view the article on Cantech LetterVancouver-based RepliCel Life Sciences (TSXV:RP) concentrated on...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.